重组人碱性成纤维细胞生长因子治疗烧伤及皮肤损伤的临床研究

Recombinant Human Bas ic Fibroblast Growth Factor in Treating Burns and Other Skin Injuries

目的探讨烧伤及皮肤损伤患者采用重组人碱性成纤维细胞生长因子治疗的临床效果。方法将我院60例烧伤及皮肤损伤患者随机分为观察组与对照组各30例,给予对照组常规治疗,观察组施加重组人碱性成纤维细胞生长因子治疗,对比两组的临床效果。结果对照组浅Ⅱ度、深Ⅱ度、供皮区、肉芽、外伤与慢性创面的愈合时间均明显高于观察组;观察组不良反应发生率以6.7%明显低于对照组的33.3%(P<0.05)。结论烧伤及皮肤损伤患者采用重组人碱性成纤维细胞生长因子治疗后的效果显著,值得推广。

Objective To explore the burns and skin damage in patients using recombinant human basic fibroblast growth factor in the treatment of clinical effect.Methods 60 cases of our hospital observation group and control group 30 cases of patients with burns and skin damage were randomized into the control group given conventional treatment, applying recombinant human basic fibroblast growth factor treatment observation group, the clinical effect of contrast between the two groups.Results Control group superficial Ⅱ degree, deep Ⅱ degree, donor sites and healing time granulation, trauma and chronic wounds were significantly higher than in the observation group;incidence of adverse reactions to 6.7% in the observation group was significantly lower than33.3% in the control group(P<0.05).Conclusion Burns and skin damage in patients using the effect of recombinant human basic fibroblast growth factor significantly after treatment, it is worth promoting.